Nichols TC - Search Results

1

Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice.

Xu L, Mei M, Haskins ME, Nichols TC, O'donnell P, Cullen K, Dillow A, Bellinger D, Ponder KP. Xu L, et al. Among authors: nichols tc. Thromb Res. 2007;120(2):269-80. doi: 10.1016/j.thromres.2006.09.010. Epub 2006 Nov 7. Thromb Res. 2007. PMID: 17095052

2

The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A.

Nichols TC, Bellinger DA, Reddick RL, Smith SV, Koch GG, Davis K, Sigman J, Brinkhous KM, Griggs TR, Read MS. Nichols TC, et al. Blood. 1993 May 15;81(10):2644-51. Blood. 1993. PMID: 8490173 Free article.

3

Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia.

Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE. Monahan PE, et al. Among authors: nichols tc. Gene Ther. 1998 Jan;5(1):40-9. doi: 10.1038/sj.gt.3300548. Gene Ther. 1998. PMID: 9536263

4

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector.

Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA. Herzog RW, et al. Among authors: nichols tc. Nat Med. 1999 Jan;5(1):56-63. doi: 10.1038/4743. Nat Med. 1999. PMID: 9883840

5

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors.

Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin HF, Stafford DW, Patel S, Thompson AR, Nichols T, Read MS, Bellinger DA, Brinkhous KM, Kay MA. Snyder RO, et al. Nat Med. 1999 Jan;5(1):64-70. doi: 10.1038/4751. Nat Med. 1999. PMID: 9883841

6

Persistent expression of canine factor IX in hemophilia B canines.

Chao H, Samulski R, Bellinger D, Monahan P, Nichols T, Walsh C. Chao H, et al. Gene Ther. 1999 Oct;6(10):1695-704. doi: 10.1038/sj.gt.3301024. Gene Ther. 1999. PMID: 10516718

7

Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver.

Wang L, Nichols TC, Read MS, Bellinger DA, Verma IM. Wang L, et al. Among authors: nichols tc. Mol Ther. 2000 Feb;1(2):154-8. doi: 10.1006/mthe.2000.0031. Mol Ther. 2000. PMID: 10933925 Free article.

8

Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogs.

Russell KE, Read MS, Bellinger DA, Leitermann K, Rup BJ, McCarthy KP, Keith JC Jr, Khor SP, Schaub RG, Nichols TC. Russell KE, et al. Among authors: nichols tc. Thromb Haemost. 2001 Mar;85(3):445-9. Thromb Haemost. 2001. PMID: 11307812

9

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy.

Mount JD, Herzog RW, Tillson DM, Goodman SA, Robinson N, McCleland ML, Bellinger D, Nichols TC, Arruda VR, Lothrop CD Jr, High KA. Mount JD, et al. Among authors: nichols tc. Blood. 2002 Apr 15;99(8):2670-6. doi: 10.1182/blood.v99.8.2670. Blood. 2002. PMID: 11929752 Free article.

10

Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys.

McCarthy K, Stewart P, Sigman J, Read M, Keith JC Jr, Brinkhous KM, Nichols TC, Schaub RG. McCarthy K, et al. Among authors: nichols tc. Thromb Haemost. 2002 May;87(5):824-30. Thromb Haemost. 2002. PMID: 12038784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters